(Bloomberg Business) — The Food and Drug Administration today warned that two drugs with similar names have been mixed up dozens of times by doctors and pharmacists.
The antidepressant Brintellix and the anti-clotting agent Brilinta have been confused at least 50 times. Though the agency has no records of cases in which patients took the wrong drug, it's concerned enough to alert the public.
Recommended For You
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
